Decision No. 5/ISAF/2024 of the Director of the Pharmaceutical Administration Bureau; (56 page(s), in Chinese), (56 page(s), in Punjabi)

Draft resolution number 1134, 23 December 2022;; (9 page(s), in Portuguese)

Normative Instruction number 131, 30 March 2022; (4 page(s), in Portuguese)